Bobak R. Azamian Sells 8,000 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Stock

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) CEO Bobak R. Azamian sold 8,000 shares of the firm’s stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $17.23, for a total transaction of $137,840.00. Following the sale, the chief executive officer now owns 902,106 shares in the […]

Related Keywords

United States ,Canada ,Ohio ,America ,William Blair ,Bobakr Azamian ,Tarsus Pharmaceuticals ,Group Plc ,Nasdaq ,Tarsus Pharmaceuticals Inc ,Quarter For Tarsus Pharmaceuticals ,Institutional Trading Of Tarsus Pharmaceuticals ,Simplex Trading ,News Ratings For Tarsus Pharmaceuticals Daily ,Securities Exchange Commission ,Tarsus Pharmaceuticals Stock Performance ,Royal Bank ,Get Free Report ,Exchange Commission ,Employees Retirement System ,General Group Plc ,Tarsus Pharmaceuticals Daily ,Nasdaq Tars ,Stars ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,